Stay updated on Clinical Trial: Reboxetine in Narcolepsy & Cataplexy

Sign up to get notified when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now includes an expanded Locations section listing study sites by state (Alabama, California, Colorado, Florida, Georgia, Indiana, Maryland, New York, Ohio, South Carolina, Texas) and a revision tag v3.3.3. Per-state location headers were consolidated under a single Locations section.
    Difference
    1%
    Check dated 2025-12-23T10:21:55.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision tag updated from v3.2.0 to v3.3.2. No changes to the study details or page functionality were observed.
    Difference
    0.1%
    Check dated 2025-11-24T19:03:25.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    - Removal of the government funding lapse notice from the page. The notice previously informed users about potential delays and directed readers to external sources for operating status updates.
    Difference
    0.4%
    Check dated 2025-11-17T18:04:53.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page shows a visual refresh with minor layout and header changes; core trial information (title, conditions, eligibility criteria, primary outcome, enrollment, and locations) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:36:08.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    6%
    Check dated 2025-10-05T17:30:11.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    The page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) have been removed.
    Difference
    0.9%
    Check dated 2025-09-28T10:35:33.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Reboxetine in Narcolepsy & Cataplexy

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.